Mono Pharmacare share price
You have to be logged in to add this to Watchlist.- ₹11.90(0.00%)February 12, 2026 15:40:14 PM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 19.60 K
Mono Pharmacare is trading 0.00% upper at Rs 11.90 as compared to its last closing price. Mono Pharmacare has been trading in the price range of 0.00 & 0.00. Mono Pharmacare has given -21.71% in this year & 9.68% in the last 5 days. Mono Pharmacare has TTM P/E ratio 47.89 as compared to the sector P/E of 30.79.The company posted a net profit of 0.02 Crores in its last quarter.Listed peers of Mono Pharmacare include Torrent Pharmaceuticals (-0.18%), Dr Reddy's Laboratories (-0.51%), Divi's Laboratories (-0.13%).The Mutual Fund holding in Mono Pharmacare was at -% in . The MF holding has - from the last quarter. The FII holding in Mono Pharmacare was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 14, 2026, 11:37 AM UTC
- Debt To EquityHigher than industry1.72The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.24The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,074.05 | -0.18 | 1,37,562.02 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,268.00 | -0.51 | 1,05,788.83 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,180.45 | -0.13 | 1,64,071.53 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Neutral | 1,698.00 | -0.97 | 4,07,849.42 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Bearish | 1,331.70 | 0.16 | 1,07,570.97 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-29 | Quarterly Results & Others |
| 2025-11-28 | Quarterly Results & Others |
| 2025-11-21 | Quarterly Results & Others |
| 2025-11-14 | Quarterly Results & Others |
| 2025-08-26 | Others |
- IndustryBiotechnology & Drugs
- ISININE0OIP01012
- BSE Code
- NSE CodeMONOPHARMA
Mono Pharmacare is trading at 11.90 as on Thu Feb 12 2026 10:10:14. This is 0.00% upper as compared to its previous closing price of 11.90.
The market capitalization of Mono Pharmacare is 21.03 Cr as on Thu Feb 12 2026 10:10:14.
The 52 wk high for Mono Pharmacare is 28.90 whereas the 52 wk low is 9.45
Mono Pharmacare can be analyzed on the following key metrics -
- TTM P/E: 47.89
- Sector P/E: 30.79
- Dividend Yield: 0.00%
- D/E ratio: 1.76
Mono Pharmacare reported a net profit of 3.09 Cr in 2025.